On the 19th, the second day of SK Bioscience’s listing, it failed in’Daesangsang’ (two consecutive caps after the initial price doubled from the public offering). Rather, it fell nearly 2% compared to the previous day, beating the market’s expectations.
SK Bioscience’s stock price fell 1.48% from the day before the 19th, the second day of listing. Shutterstock
Mirae Asset Daewoo MTS once stopped due to a surge in orders
On this day, in the KOSPI market, SK Biosciences finished trading at 166,000 won, down 2500 won (1.48%) from the previous day. The atmosphere at the beginning of the chapter was okay. With the opening, it started at 184,000 won, an 8.88% increase from the previous day, and then increased to 190,000 won (12.43%), but the rise continued to decrease in the afternoon. Eventually, the market turned downward and did not recover until the close of the market. Foreigners and institutions net sold 12.3 billion won and 30 billion won, respectively, and individuals net bought 168.6 billion won and received them.
The market cap fell to 12,7373 trillion won, down one notch from 28th to 29th (excluding preferred stocks) in the KOSPI market cap. The decline in the stock price on this day can be interpreted as a result of the realization of profits from rising stock prices and the fall of the KOSPI due to the increase in the US 10-year Treasury bond interest rate.
The stock price fell, but the trading volume exploded. On this day, 12,200,000 shares were traded. It is almost 14 times the previous day (87,6189 weeks). Considering that SK Bioscience’s available distribution amount is about 8.9 million shares, it is estimated that the change of hands was frequent. It even came to the end of “It’s like a battlefield of danta.” The transaction amount reached 2,183.9 billion won, ranking first in the KOSPI and KOSDAQ markets on this day. Samsung Electronics’ transaction volume (1,286.9 billion won) is also a figure that far exceeds.
Some securities companies’ mobile trading systems (MTS), such as Mirae Asset Daewoo, were disrupted at one time in the morning as investor transactions were rushing. Mirae Asset Daewoo said, “The number of customers who want to trade stocks such as SK Bioscience has temporarily increased, causing a connection error to some MTS, etc.,” and said, “In the case of victims, we will provide reasonable compensation based on the relevant regulations.” However, the complaints of users were flooded. In the internet stock community, there were articles such as “I missed the timing to sell because I couldn’t order” and “I couldn’t buy or sell (stock).”
SK Biosciences entered the stock market on the 18th, the date of listing, up to 169,000 won, with so-called’tasang’ (the upper limit after the initial price was formed by double the public offering price). In the general subscription that took place on the 9th to 10th, a total margin of 63,619.8 billion won was gathered to record a record high.
Reporter Hwang Eui-young [email protected]
